Top

Drug Safety

Published in:

01-02-2007 | Original Research Article

Psychotropic Medications and the Risk of Fracture

A Meta-Analysis

Authors: Dr Bahi Takkouche, Agustín Montes-Martínez, Sudeep S. Gill, Mahyar Etminan

Published in: Drug Safety | Issue 2/2007

Abstract

Background: Older adults throughout the developed world are at significant risk of osteoporotic fractures. Many studies have examined the relationship between the use of psychotropic medications and the risk of fractures, but these studies have reported conflicting results.

Purpose: To resolve discrepancies, we carried out a meta-analysis to assess the risk of fractures among users of several classes of psychotropic drugs.

Data sources: We retrieved studies published in any language by systematically searching MEDLINE, LILACS, EMBASE and ISI Proceedings databases and by manually examining the bibliographies of the articles retrieved electronically as well as those of recent reviews.

Study selection: We included 98 cohort and case-control studies, published in 46 different articles, that reported relative risk (RR) estimates and confidence intervals (CIs) or sufficient data to calculate these values.

Data synthesis: Study-specific RRs were weighted by the inverse of their variance to obtain fixed- and random effects pooled estimates. The random effects RR of fractures was 1.34 (95% CI 1.24, 1.45) for benzodiazepines (23 studies), 1.60 (95% CI 1.38, 1.86) for antidepressants (16 studies), 1.54 (95% CI 1.24, 1.93) for non-barbiturate antiepileptic drugs (13 studies), 2.17 (95% CI 1.35, 3.50) for barbiturate antiepileptic drugs (five studies), 1.59 (1.27, 1.98) for antipsychotics (12 studies), 1.15 (95% CI 0.94, 1.39) for hypnotics (13 studies) and 1.38 (95% CI 1.15, 1.66) for opioids (six studies). For non-specified psychotropic drugs (10 studies), the pooled RR was 1.48 (95% CI 1.41, 1.59).

Limitations: Main concerns were the potential for residual confounding and for publication bias.

Conclusion: Globally, the increase in the risk of fractures among psychotropic drug users is moderate. Further research is needed, especially to examine high-risk populations and newer medications. Future studies should be prospective and emphasise control of confounding bias.

Available only for authorised users

Data from case-control studies on study-specific odds ratios (with 95% CIs) for fractures with psychotropic drugs are available as supplementary material from URL: http://drugsafety.adisonline.com (table I).

Data from cohort studies on study-specific relative risks (with 95% CIs) for fractures with psychotropic drugs are available as supplementary material from URL: http://drugsafety.adisonline.com (table II).

Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997; 7: 407–13PubMedCrossRef

Stevens JA, Olson S. Reducing falls and resulting hip fractures among older women. MMWR Recomm Rep 2000; 49(RR-2): 3–12PubMed

Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS drugs 2003; 17: 825–37PubMedCrossRef

International Osteoporosis Foundation. Osteoporosis in Europe. Indicators of progress and outcomes from the European Parliament Osteoporosis Interest Group and European Union Osteoporosis Consultation Panel Meeting, 2004, p2 [online]. Available from URL: http://www.osteofound.org/advocacy_policy/eu_policy_project/pdf/indicators_of_progress.pdf. [Accessed 2006 Sep 21]

Chrischilles E, Shireman T, Wallace R. Costs and health effects of ostoporotic fracture. Bone 1994; 15: 377–86PubMedCrossRef

Centers for Disease Control and Prevention. Hip fractures among older adults [online]. Available from URL: http://www.cdc.gov/ncipc/factsheets/adulthipfx.htm [Accessed 2006 Dec 2]

Campbell AJ, Robertson MC, Gardner MM, et al. Psychotropic medicine withdrawal and a home-based exercise program to prevent falls: a randomized controlled trial. J Am Geriatr Soc 1999; 47: 850–3PubMed

Tinetti ME. Preventing falls in elderly persons. N Engl J Med 2003; 348: 42–9PubMedCrossRef

Kannus P, Sievanen H, Palvanen M, et al. Prevention of falls and consequent injuries in elderly people. Lancet 2005; 366: 1885–93PubMedCrossRef

10.

Schoofs M, vand der Klift M, Hofman A, et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med 2003; 139: 476–82PubMed

11.

Paulose-Ram R, Jonas BS, Orwig D, et al. Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994. J Clin Epidemiol 2004; 57: 309–17PubMedCrossRef

12.

Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy and the United Kingdom. J Clin Psychiatry 2002; 63: 817–25PubMedCrossRef

13.

Forsén L, Meyer HE, Søgaard AJ, et al. Mental distress and risk of hip fracture. Do broken hearts lead to broken bones? J Epidemiol Community Health 1999; 53: 343–7PubMedCrossRef

14.

Pierfitte C, Macouillard G, Thicoepe M, et al. Benzodiazepines and hip fractures in elderly people: case-control study. BMJ 2001; 322: 704–8PubMedCrossRef

15.

Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30–9PubMed

16.

Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008–12PubMedCrossRef

17.

French DD, Campbell R, Spehar A, et al. Outpatient medications and hip fractures in the US. A national veterans study. Drugs aging 2005; 22: 877–85PubMedCrossRef

18.

Bhutta AT, Cleves MA, Casey PH, et al. Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA. 2002; 288: 728–37PubMedCrossRef

19.

Takkouche B, Etminan M, Montes-Martinez A. Personal use of hair dyes and risk of cancer: A meta-analysis. JAMA 2005; 293: 2516–25PubMedCrossRef

20.

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trial. 1986; 7: 177–88CrossRef

21.

Takkouche B, Cadarso-Suarez C, Spiegelman D. Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol 1999; 150: 206–15PubMedCrossRef

22.

Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–34PubMedCrossRef

23.

Costa-Bouzas J, Takkouche B, Cadarso-Suarez C, et al. HepiMA: software for the identification of heterogeneity in meta-analysis. Comput Methods Programs Biomed 2001; 64: 101–7PubMedCrossRef

24.

Wysowski DK, Baum C, Ferguson WJ, et al. Sedative-hynotic and the risk of hip fracture. J Clin Epidemiol 1996; 49: 111–3PubMedCrossRef

25.

Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. N Eng J Med 1991; 324: 1326–31CrossRef

26.

Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hip fracture. N Eng J Med 1987; 316: 363–9CrossRef

27.

Sernbo I, Hansson A, Johnell O. Drug consumption in patients with hip fractures compared with controls. Compr Gerontol [A] 1987; 1: 93–6

28.

Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262: 3303–7PubMedCrossRef

29.

Stevens A, Mulrow C. Drugs affecting postural stability and other risk factors in the hip fracture epidemic: case-control study. Community Med 1989; 11: 27–34PubMed

30.

Jensen J, Nielsen LH, Lyhne N, et al. Drugs and femoral neck fracture: a case-control study. J Intern Med 1991; 229: 29–33PubMedCrossRef

31.

Cumming RG, Klineberg RJ. Psychotropics, thiazide diuretics and hip fractures in the elderly. Med J Aust 1993; 158: 414–7PubMed

32.

Lichtenstein MJ, Griffin MR, Cornell JE, et al. Risk factors for hip fractures occurring in the hospital. Am J Epidemiol 1994; 140: 830–8PubMed

33.

Herings R, Stricker BH, de Boer A, et al. Benzodiazepines and the risk of falling leading to femur fractures: Dosage more important than elimination half-life. Arch Intern Med 1995; 155: 1801–7PubMedCrossRef

34.

Schwab M, Roder F, Aleker T, et al. Psychotropic drug use, falls and hip fracture in the elderly. Aging Clin Exp Res 2000; 12: 234–9

35.

Sgadari A, Lapane K, Mor V, et al. Oxidative and nonoxidative benzodiazepines and the risk of femur fracture. J Clin Psychopharmacol 2000; 20: 234–9PubMedCrossRef

36.

Wang PS, Bohm RL, Glynn RJ, et al. Zolpidem use and hip fractures in older people. J Am Geriatr Soc 2001; 49: 1685–90PubMedCrossRef

37.

da Silva Freire Coutinho E, Dutra Da Silva S. Uso de medicamentos como fator de risco para fratura grave decorrente de queda em idosos. Cad Saude Publica 2002; 18: 1359–66CrossRef

38.

Schlienger RG, Kraenzlin ME, Jick SS, et al. Use of β-blockers and risk of fractures. JAMA 2004; 292: 1326–32PubMedCrossRef

39.

Vestergaard P, Rejmark L, Mosekilde L. Fracture associated with use of antepileptic drugs. Epilepsia 2004; 45: 1330–7PubMedCrossRef

40.

Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med 1995; 332: 767–73PubMedCrossRef

41.

Guo Z, Wills P, Viitanen M, et al. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 year old: a community-based prospective study. Am J Epidemiol 1998; 148: 887–92PubMedCrossRef

42.

Jacqmin-Gadda H, Fourrier A, Commenges D, et al. Risk factors for fractures in the elderly. Epidemiol 1998; 9: 417–23CrossRef

43.

Vestergaard P, Tigaran S, Rejnmark L, et al. Fracture risk is increased in epilepsy. Acta Neurol Scand 1999; 99: 269–75PubMedCrossRef

44.

Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medication and risk of fractures in older women. Arch Intern Med 2003; 163: 949–57PubMedCrossRef

45.

Hasselman CT, Vogt MT, Stone KL, et al. Foot and ankle fractures in elderly white women. J Bone Joint Surg 2003; 85A: 820–4

46.

Wagner AK, Zhang F, Soumerai SB, et al. Benzodiazepine use and hip fractures in the elderly. Arch Intern Med 2004; 164: 1567–72PubMedCrossRef

47.

Ray WA, Griffin MR, Malcolm E. Cyclic antidepressants and the risk of hip fracture. Arch Intern Med 1991; 151: 754–6PubMedCrossRef

48.

Herings RMC, Stricker BHC, de Boer A, et al. Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol 1996; 49: 115–19PubMedCrossRef

49.

Gambassi G, Lapane KL, Sgadari A, et al. Elderly patients, use of antidepressants, and hip fracture [letter]. Lancet 1998; 352: 400PubMedCrossRef

50.

Liu B, Anderson G, Mittman N, et al. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998; 351: 1303–7PubMedCrossRef

51.

Partanen J, Heikkinen J, Jamsa T, et al. Characteristics of lifetime factors, bone metabolism and bone mineral density in patients with hip fracture. J Bone Miner Metab 2002; 20: 367–75PubMedCrossRef

52.

Hubbard R, Farrington P, Smith C, et al. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 2003; 158: 77–84PubMedCrossRef

53.

Hugenholtz GWK, Heerdink ER, van Staa TP, et al. Risk of hip/femur in patients using antipsychotics. Bone 2005; 37: 864–70PubMedCrossRef

54.

Brocklehurst JC, Exton-Smith AN, Lempert Barber SM, et al. Barbiturates and fractures. BMJ 1977; 2: 699–700CrossRef

55.

Paganini-Hill A, Ross RK, Gerkins VR, et al. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981; 95: 28–31PubMed

56.

Heidrich FE, Stergachis A, Gross KM. Diuretic drug use and the risk for hip fracture. Ann Intern Med 1991; 115: 1–6PubMed

57.

Jackson JA, Riggs MW, Spiekerman AM. Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 1992; 304: 4–8PubMedCrossRef

58.

Poor G, Atkinson EJ, O’Fallon WM, et al. Predictors of hip fractures in elderly men. J Bone Miner Res 1995; 10: 1900–7PubMedCrossRef

59.

Scane AC, Francis RM, Sutcliffe AM, et al. Case-control study of the pathogenesis and sequelae of symtomatica vertebral fractures in men. Osteoporos Int 1999; 9: 91–7PubMedCrossRef

60.

Bischof F, Basu D, Pettifor JM. Pathological long-bone fractures in residents with cerebral palsy in a long-term care facility in South Africa. Develop Med Child Neurol 2002; 44: 119–22PubMedCrossRef

61.

Ryder KM, Williams J, Womack C, et al. Appendicular fractures: a significant problem among institutionalized adults with developmental disabilities. Am J Ment Retard 2003; 108: 340–6PubMedCrossRef

62.

Annegers JF, Melton LJ, Sun C, et al. Risk of age-related fractures in patients with unprovoked seizures. Epilepsia 1989; 30: 348–55PubMedCrossRef

63.

Rashiq S, Logan RFA. Role of drugs in fractures of the femoral neck. BMJ 1986; 292: 861–3PubMedCrossRef

64.

Shorr RI, Griffin MR, Daugherty JR, et al. Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol 1992; 47: 111–5CrossRef

65.

Card T, West J, Hubbard R, et al. Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 2004; 53: 251–5PubMedCrossRef

66.

Taggart HM. Do drugs affect the risk of hip fracture in elderly women? J Am Geriatr Soc 1988; 36: 1006–10PubMed

67.

Grisso JA, Kelsey JL, O’Brien LA, et al. Risk factors for hip fracture in men. Am J Epidemiol 1997; 145: 786–93PubMedCrossRef

68.

Bae JM, Koo HW, Jung KO, et al. A cohort study of the association between psychotropics and hip fracture in Korean elderly women. J Korean Med Sci 2002; 17: 65–70PubMed

69.

Sutton AJ, Abrams KR, Jones DR, et al. Methods for meta-analysis in medical research. Chichester: Wiley, 2000: 118

70.

Coursol A, Wagner EE. Effect of positive findings on submission and acceptance rates: a note on meta-analysis bias. Prof Psychol-Res Pr 1986; 17: 136–7CrossRef

71.

Shorr RI. Review: psychotropic drugs increase the risk of falls in older people. Evid Based Ment Health 1999; 2: 95CrossRef

72.

Seeger JD, Williams PL, Walker AM. An application of propensity score matching using claims data. Pharmacoepidemiol Drug Saf 2005; 14: 465–76PubMedCrossRef

73.

Kinjo M, Setoguchi S, Schneeweiss S, et al. Bone mineral density in subjects using central nervous system-active medications. Am J Med 2005; 118: 1414PubMedCrossRef

74.

Schneeweiss S, Wang PS. Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J Clin Psychopharmacol 2004; 24: 632–8PubMedCrossRef

Title: Psychotropic Medications and the Risk of Fracture
A Meta-Analysis
Authors: Dr Bahi Takkouche
Agustín Montes-Martínez
Sudeep S. Gill
Mahyar Etminan
Publication date: 01-02-2007
Publisher: Springer International Publishing
Published in: Drug Safety / Issue 2/2007
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI: https://doi.org/10.2165/00002018-200730020-00006

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Psychotropic Medications and the Risk of Fracture

A Meta-Analysis

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2007

Open-Label Extension Studies

Safety Profile of Rosuvastatin

Potential Use of Data-Mining Algorithms for the Detection of ‘Surprise’ Adverse Drug Reactions

Suicidality and Antiepileptic Drugs

Drug-Induced Thrombocytopenia

Use of Contemporary Antidepressants during Breastfeeding